Literature DB >> 21726451

Immunogenicity of autoantigens.

Christina Backes1, Nicole Ludwig, Petra Leidinger, Christian Harz, Jana Hoffmann, Andreas Keller, Eckart Meese, Hans-Peter Lenhof.   

Abstract

BACKGROUND: Autoantibodies against self-antigens have been associated not only with autoimmune diseases, but also with cancer and are even found in healthy individuals. The mechanism causing the autoantibody response remains elusive for the majority of the immunogenic antigens. To deepen the understanding of autoantibody responses, we ask whether natural-occurring, autoimmunity-associated and tumor-associated antigens have structural or biological features related to the immune response. To this end, we have carried out the most comprehensive in-silicio study of different groups of autoantigens including large antigen sets identified by our groups combined with publicly available antigen sets.
RESULTS: We found evidence for an enrichment of genes with a larger exon length increasing the probability of the occurrence of potential immunogenic features such as mutations, SNPs, immunogenic sequence patterns and structural epitopes, or alternative splicing events. While SNPs seem to play a more central role in autoimmunity, somatic mutations seem to be stronger enriched in tumor-associated antigens. In addition, antigens of autoimmune diseases are different from other antigen sets in that they appear preferentially secreted, have frequently an extracellular location, and they are enriched in pathways associated with the immune system. Furthermore, for autoantibodies in general, we found enrichment of sequence-based properties including coiled-coils motifs, ELR motifs, and Zinc finger DNA-binding motifs. Moreover, we found enrichment of proteins binding to proteins or nucleic acids including RNA and enrichment of proteins that are part of ribosome or spliceosome. Both, homologies to proteins of other species and an enrichment of ancient protein domains indicate that immunogenic proteins are evolutionary conserved and that mimicry might play a central role.
CONCLUSIONS: Our results provide evidence that proteins which i) are evolutionary conserved, ii) show specific sequence motifs, and iii) are part of cellular structures show an increased likelihood to become autoimmunogenic.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726451      PMCID: PMC3149588          DOI: 10.1186/1471-2164-12-340

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


  66 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Predicting coiled coils from protein sequences.

Authors:  A Lupas; M Van Dyke; J Stock
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

Review 3.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

Review 4.  Molecular mimicry as a mechanism for virus-induced autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

5.  Long charge-rich alpha-helices in systemic autoantigens.

Authors:  J G Dohlman; A Lupas; M Carson
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

6.  Combining gene expression signatures and autoantibody profiles in human meningioma.

Authors:  A Keller; N Ludwig; N Comtesse; W Henn; W-I Steudel; H-P Lenhof; E Meese
Journal:  Gene Ther       Date:  2008-08-14       Impact factor: 5.250

Review 7.  The role of autoantibodies in autoimmune disease.

Authors:  Y Naparstek; P H Plotz
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

Authors:  S F Winter; J D Minna; B E Johnson; T Takahashi; A F Gazdar; D P Carbone
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

9.  Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.

Authors:  R Lubin; B Schlichtholz; D Bengoufa; G Zalcman; J Trédaniel; A Hirsch; C Caron de Fromentel; C Preudhomme; P Fenaux; G Fournier; P Mangin; P Laurent-Puig; G Pelletier; M Schlumberger; F Desgrandchamps; A Le Duc; J P Peyrat; N Janin; B Bressac; T Soussi
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

10.  Novel autoantigens immunogenic in COPD patients.

Authors:  Petra Leidinger; Andreas Keller; Sabrina Heisel; Nicole Ludwig; Stefanie Rheinheimer; Veronika Klein; Claudia Andres; Jürg Hamacher; Hanno Huwer; Bernhard Stephan; Ingo Stehle; Hans-Peter Lenhof; Eckart Meese
Journal:  Respir Res       Date:  2009-03-12
View more
  26 in total

1.  The immune system, natural autoantibodies and general homeostasis in health and disease.

Authors:  A Poletaev; P Boura
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

2.  Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

Authors:  Grazyna Adamus
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-09       Impact factor: 4.799

3.  Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases.

Authors:  Adriana Ricciuti; Alessandra De Remigis; Melissa A Landek-Salgado; Ludovica De Vincentiis; Federica Guaraldi; Isabella Lupi; Shintaro Iwama; Gary S Wand; Roberto Salvatori; Patrizio Caturegli
Journal:  J Clin Endocrinol Metab       Date:  2014-02-25       Impact factor: 5.958

4.  A novel SNP in promoter region of RP11-3N2.1 is associated with reduced risk of colorectal cancer.

Authors:  Ding Ye; Yunqing Hu; Fangyuan Jing; Yingjun Li; Simeng Gu; Xiyi Jiang; Yingying Mao; Qilong Li; Mingjuan Jin; Kun Chen
Journal:  J Hum Genet       Date:  2017-10-05       Impact factor: 3.172

Review 5.  Perception of self: distinguishing autoimmunity from autoinflammation.

Authors:  Tessa S van Kempen; Mark H Wenink; Emmerik F A Leijten; Timothy R D J Radstake; Marianne Boes
Journal:  Nat Rev Rheumatol       Date:  2015-05-12       Impact factor: 20.543

6.  The exon 29 c.3535A>T in the alpha-2-macroglobulin gene causing aberrant splice variants is associated with mastitis in dairy cattle.

Authors:  Xiuge Wang; Jinming Huang; Lihong Zhao; Changfa Wang; Zhihua Ju; Qiuling Li; Chao Qi; Yan Zhang; Zebin Zhang; Wei Zhang; Minghai Hou; Jinduo Yuan; Jifeng Zhong
Journal:  Immunogenetics       Date:  2012-08-26       Impact factor: 2.846

7.  Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.

Authors:  Jon J Ladd; Timothy Chao; Melissa M Johnson; Ji Qiu; Alice Chin; Rebecca Israel; Sharon J Pitteri; Jianning Mao; Mei Wu; Lynn M Amon; Martin McIntosh; Christopher Li; Ross Prentice; Nora Disis; Samir Hanash
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

8.  Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.

Authors:  Qing Shao; Pengfei Ren; Yang Li; Bo Peng; Liping Dai; Ningjing Lei; Wu Yao; Gang Zhao; Linggen Li; Jianying Zhang
Journal:  Int J Oncol       Date:  2012-06-12       Impact factor: 5.650

9.  Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts.

Authors:  Kourtney Trudgen; Nada H Khattar; Eric Bensadoun; Susanne Arnold; Arnold J Stromberg; Edward A Hirschowitz
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  SPRi-based strategy to identify specific biomarkers in systemic lupus erythematosus, rheumatoid arthritis and autoimmune hepatitis.

Authors:  Elvire Beleoken; Hervé Leh; Armelle Arnoux; Béatrice Ducot; Claude Nogues; Eleonora De Martin; Catherine Johanet; Didier Samuel; Mohammad Zahid Mustafa; Jean-Charles Duclos-Vallée; Malcolm Buckle; Eric Ballot
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.